Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human and entomological surveillance of Toscana virus in the Emilia-Romagna region, Italy, 2010 to 2012.
Calzolari M, Angelini P, Finarelli AC, Cagarelli R, Bellini R, Albieri A, Bonilauri P, Cavrini F, Tamba M, Dottori M, Gaibani P, Natalini S, Maioli G, Pinna M, Mattivi A, Sambri V, Pierro A, Landini MP, Rossini G, Squintani G, Cinotti S, Varani S, Vocale C, Bedeschi E. Calzolari M, et al. Among authors: gaibani p. Euro Surveill. 2014 Dec 4;19(48):20978. doi: 10.2807/1560-7917.es2014.19.48.20978. Euro Surveill. 2014. PMID: 25496572 Free article.
Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections?
Gatti M, Rinaldi M, Bonazzetti C, Gaibani P, Giannella M, Viale P, Pea F. Gatti M, et al. Among authors: gaibani p. Antimicrob Agents Chemother. 2023 Nov 15;67(11):e0096923. doi: 10.1128/aac.00969-23. Epub 2023 Oct 16. Antimicrob Agents Chemother. 2023. PMID: 37843260 Free PMC article.
Corrigendum to: "Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)" Clinical Microbiology and Infection 26 (2020) 1545-1553.
Bartoletti M, Giannella M, Scudeller L, Tedeschi S, Rinaldi M, Bussini L, Fornaro G, Pascale R, Pancaldi L, Pasquini Z, Trapani F, Badia L, Campoli C, Tadolini M, Attard L, Puoti M, Merli M, Mussini C, Menozzi M, Meschiari M, Codeluppi M, Barchiesi F, Cristini F, Saracino A, Licci A, Rapuano S, Tonetti T, Gaibani P, Ranieri VM, Viale P; PREDICO study group. Bartoletti M, et al. Among authors: gaibani p. Clin Microbiol Infect. 2023 Jun;29(6):817. doi: 10.1016/j.cmi.2023.02.017. Epub 2023 Mar 1. Clin Microbiol Infect. 2023. PMID: 36868355 Free PMC article. No abstract available.
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF).
Gatti M, Rinaldi M, Tonetti T, Gaibani P, Siniscalchi A, Viale P, Pea F. Gatti M, et al. Among authors: gaibani p. Int J Antimicrob Agents. 2023 Aug;62(2):106852. doi: 10.1016/j.ijantimicag.2023.106852. Epub 2023 May 14. Int J Antimicrob Agents. 2023. PMID: 37192727
Pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam in peritoneal fluid in an orthotopic liver transplant recipient affected by bacteraemic complicated intra-abdominal infection due to OXA-181-producing Klebsiella pneumoniae.
Gatti M, Rinaldi M, Gaibani P, Siniscalchi A, Viale P, Pea F. Gatti M, et al. Among authors: gaibani p. J Glob Antimicrob Resist. 2023 Sep;34:268-270. doi: 10.1016/j.jgar.2023.05.007. Epub 2023 Jun 1. J Glob Antimicrob Resist. 2023. PMID: 37269975 Free article. No abstract available.
144 results